Yuyu Pharma Inc (000225) — Cash Flow Quality Index
Yuyu Pharma Inc (000225) has a Cash Flow Quality Index of 8.92x as of December 2025. Operating cash flow of ₩12.35 Billion exceeds net income of ₩1.39 Billion, indicating high earnings quality where cash backs reported profits. Explore how much of Yuyu Pharma Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Yuyu Pharma Inc Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Yuyu Pharma Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 000225 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Yuyu Pharma Inc (2016–2025)
Year-by-year earnings quality comparison for Yuyu Pharma Inc. For live market cap and the full company financial profile, see Yuyu Pharma Inc (000225) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.95x | ₩15.88 Billion | ₩8.15 Billion | ▼ -31.9% |
| 2024 | 2.86x | ₩24.95 Billion | ₩8.72 Billion | ▲ +237.6% |
| 2020 | -2.08x | ₩-2.67 Billion | ₩1.28 Billion | ▼ -174.5% |
| 2019 | 2.79x | ₩13.19 Billion | ₩4.72 Billion | ▲ +83.7% |
| 2018 | 1.52x | ₩6.11 Billion | ₩4.02 Billion | ▲ +1584.3% |
| 2017 | 0.09x | ₩561.35 Million | ₩6.22 Billion | ▼ -94.6% |
| 2016 | 1.67x | ₩9.82 Billion | ₩5.89 Billion | — |